Robert Enns

137 papers receiving 4.6k citations

Hit Papers

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial 2006 · 1.7k citations
1.7k200620262012201950010001.5k

Peers

Robert Enns
Comparison fields: 5 of 124
  • Gastroenterology 1.1k
  • Genetics 1.8k
  • Surgery 2.2k
  • Epidemiology 1.7k
  • Oncology 1.2k
Replace David H. Bruining with:
David H. Bruining United States
Byong Duk Ye South Korea
Jeong‐Sik Byeon South Korea
Michael Safdi United States
Shaji Sebastian United Kingdom
Sang Hyoung Park South Korea
Adrian J. Greenstein United States
D. Héresbach France
Arthur H. Aufses United States
Marco Daperno Italy
Robert Enns relative to David H. Bruining United States David H. Bruining's profile →
Citations per field
00.5×1.5×
David H. Bruining · 1×
Citations per year

Countries citing papers authored by Robert Enns

Since Specialization
Citations

This map shows the geographic impact of Robert Enns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Enns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Enns more than expected).

Fields of papers citing papers by Robert Enns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Enns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Enns. The network helps show where Robert Enns may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Enns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Enns Line = papers co-authored together Robert Enns links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
Hit paper breakdown →
20061655
2 2004270
3 2017254
4 2006135
5 2011133
6 2006110
7 2009103
8 2000101
9 201096
10 201284
11 201069
12 200764
13 201464
14 199956
15 201051
16 201550
17 200841
18 200241
19 201240
20 201337

About Robert Enns

Robert Enns is a scholar working on Gastroenterology, Microbiology, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 139 papers that have together received 4.8k indexed citations. Recurring topics across this work include Gastrointestinal Bleeding Diagnosis and Treatment (38 papers), Colorectal Cancer Screening and Detection (38 papers), Gastrointestinal disorders and treatments (32 papers), Gastric Cancer Management and Outcomes (30 papers), Esophageal and GI Pathology (27 papers), Gallbladder and Bile Duct Disorders (19 papers), Inflammatory Bowel Disease (15 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). The work is most often cited by research in Gastroenterology (1.1k citations), Genetics (1.8k citations), Surgery (2.2k citations), Epidemiology (1.7k citations) and Oncology (1.2k citations). Robert Enns has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Remo Panaccione, William J. Sandborn, Jeffrey D. Kent, Stefan Schreiber, Ju Li, Paul F. Pollack, Stephen B. Hanauer, Jean–Frédéric Colombel, Paul Rutgeerts and Jennifer J. Telford. Their work appears in journals such as Gastrointestinal Endoscopy, Canadian Journal of Gastroenterology and Hepatology, The American Journal of Gastroenterology, Gastroenterology and Current Gastroenterology Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026